Outsourcing Strategy for Eliminating Drug Lag

本研究从企业战略，特别是外包战略的角度探讨日本企业如何消除药品滞后问题。我们采访了美国、英国、瑞士和日本的几家制药商。因此，我们发现海外制造商将临床开发视为劳动密集型和标准化的操作，而日本制造商将其视为销售和开发的关键活动，使其操作变得复杂。

The research explores what Japanese can do to eliminate the drug lag problem from the perspective of business strategy, especially outsourcing strategy. We interviewed several drug makers in US, UK, Switzerland and Japan. As the result, we found that overseas makers regard clinical development as labor intensive and standardized operations, while Japanese makers take it as critical activities for sales as well as development, making their operations complicated.